Home
›
CASI Pharmaceuticals, Inc.
› SCHEDULE 13D/A Jan 29, 2026
CASI Pharmaceuticals, Inc. (CASIF): SCHEDULE 13D/A filed Jan 29, 2026
Form type
SCHEDULE 13D/A
Filing date
Jan 29, 2026
Accession number
0001104659-26-008171
Filer
CASI Pharmaceuticals, Inc.
(CIK 1962738)